MLchartDataset catalogue

HPV 16 E7:86-93 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-014176

A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.

Table 1. Record
IdentifierMLC-T-ONC-014176
FieldOncology and biomedicine
AbbreviationE7(86-93)
SynonymsE7(86-93) lipopeptide; HPV-16E7 (86-93); HPV 16E7 86-93 Lipopeptide Vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014176",
  "term": "HPV 16 E7:86-93 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.",
  "abbreviation": "E7(86-93)",
  "synonyms": [
    "E7(86-93) lipopeptide",
    "HPV-16E7 (86-93)",
    "HPV 16E7 86-93 Lipopeptide Vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hpv-16-e7-86-93-peptide-vaccine/"
}

Record 8,646 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.